Tag - TMDIF

Developments

Conavi completes go-public transaction

Conavi Medical has completed its reverse takeover of Titan Medical (TSX:TMD; OTC:TMDIF). The combined company (the Resulting Issuer), which will voluntarily delist from the TSX on or about October 15, 2024, and...

October 11, 2024

Developments

Landmark ESC guidelines update bodes well for Conavi’s Novasight Hybrid System as company nears completion of go-public transaction

The European Society of Cardiology (ESC) has elevated intracoronary imaging guidance by intravascular ultrasound (IVUS) or optical coherence tomography (OCT) to a Class 1A recommendation when performing percutaneous...

September 25, 2024

Feature

Conavi merger and financing to help ignite widespread adoption of next-generation Novasight Hybrid intravascular imaging platform

Conavi Medical’s reverse merger with Titan Medical (TSX: TMD; OTC: TMDIF), which is expected to close in July 2024, and concurrent financing are anticipated to cultivate an investor network to help fund the expansion of...

April 2, 2024

Tag - TMDIF

Conavi completes go-public transaction

Landmark ESC guidelines update bodes well for Conavi’s Novasight Hybrid System as company nears completion of go-public transaction

Conavi merger and financing to help ignite widespread adoption of next-generation Novasight Hybrid intravascular imaging platform

General

More